Balcer LJ - Search Results

1

Measuring the rate of progression in Friedreich ataxia: implications for clinical trial design.

Friedman LS, Farmer JM, Perlman S, Wilmot G, Gomez CM, Bushara KO, Mathews KD, Subramony SH, Ashizawa T, Balcer LJ, Wilson RB, Lynch DR. Friedman LS, et al. Among authors: balcer lj. Mov Disord. 2010 Mar 15;25(4):426-32. doi: 10.1002/mds.22912. Mov Disord. 2010. PMID: 20063431 Free PMC article.

2

Neuro-ophthalmology of the pregeniculate afferent visual system. Developments in 1996 (Part I).

Balcer LJ, Lynch DR, Galetta SL. Balcer LJ, et al. J Neuroophthalmol. 1997 Mar;17(1):60-71. J Neuroophthalmol. 1997. PMID: 9093966 Review. No abstract available.

3

Neuro-ophthalmology of the pregeniculate afferent visual system. Developments in 1996 (Part II).

Balcer LJ, Lynch DR, Galetta SL. Balcer LJ, et al. J Neuroophthalmol. 1997 Jun;17(2):127-42. J Neuroophthalmol. 1997. PMID: 9176785 Review. No abstract available.

4

Near infrared muscle spectroscopy in patients with Friedreich's ataxia.

Lynch DR, Lech G, Farmer JM, Balcer LJ, Bank W, Chance B, Wilson RB. Lynch DR, et al. Among authors: balcer lj. Muscle Nerve. 2002 May;25(5):664-673. doi: 10.1002/mus.10077. Muscle Nerve. 2002. PMID: 11994959

5

Friedreich ataxia: effects of genetic understanding on clinical evaluation and therapy.

Lynch DR, Farmer JM, Balcer LJ, Wilson RB. Lynch DR, et al. Among authors: balcer lj. Arch Neurol. 2002 May;59(5):743-7. doi: 10.1001/archneur.59.5.743. Arch Neurol. 2002. PMID: 12020255 Review.

6

Contrast letter acuity as a measure of visual dysfunction in patients with Friedreich ataxia.

Lynch DR, Farmer JM, Rochestie D, Balcer LJ. Lynch DR, et al. Among authors: balcer lj. J Neuroophthalmol. 2002 Dec;22(4):270-4. doi: 10.1097/00041327-200212000-00003. J Neuroophthalmol. 2002. PMID: 12464730

7

Lack of effect of polymorphisms in dopamine metabolism related genes on imaging of TRODAT-1 in striatum of asymptomatic volunteers and patients with Parkinson's disease.

Lynch DR, Mozley PD, Sokol S, Maas NM, Balcer LJ, Siderowf AD. Lynch DR, et al. Among authors: balcer lj. Mov Disord. 2003 Jul;18(7):804-12. doi: 10.1002/mds.10430. Mov Disord. 2003. PMID: 12815660

8

Performance measures in Friedreich ataxia: potential utility as clinical outcome tools.

Lynch DR, Farmer JM, Wilson RL, Balcer LJ. Lynch DR, et al. Among authors: balcer lj. Mov Disord. 2005 Jul;20(7):777-82. doi: 10.1002/mds.20449. Mov Disord. 2005. PMID: 15747359

9

Measuring Friedreich ataxia: complementary features of examination and performance measures.

Lynch DR, Farmer JM, Tsou AY, Perlman S, Subramony SH, Gomez CM, Ashizawa T, Wilmot GR, Wilson RB, Balcer LJ. Lynch DR, et al. Among authors: balcer lj. Neurology. 2006 Jun 13;66(11):1711-6. doi: 10.1212/01.wnl.0000218155.46739.90. Neurology. 2006. PMID: 16769945 Clinical Trial.

10

Antioxidant use in Friedreich ataxia.

Myers L, Farmer JM, Wilson RB, Friedman L, Tsou A, Perlman SL, Subramony SH, Gomez CM, Ashizawa T, Wilmot GR, Mathews KD, Balcer LJ, Lynch DR. Myers L, et al. Among authors: balcer lj. J Neurol Sci. 2008 Apr 15;267(1-2):174-6. doi: 10.1016/j.jns.2007.10.008. Epub 2007 Nov 7. J Neurol Sci. 2008. PMID: 17988688 Free PMC article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

341 results

Search Page

Filters